Greenhaven Road Capital's Q3 2025 letter analyzes a -9% return, citing no AI exposure and undervalued software holdings.
Greenhaven Road reaffirms its Cellebrite thesis, citing AI tailwinds, legislative catalysts, and strong financials despite ...